JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grimm, H.
Right arrow Articles by Ermert, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grimm, H.
Right arrow Articles by Ermert, L.

J Thorac Cardiovasc Surg 2000;119:477-487
© 2000 Mosby, Inc.


CARDIOTHORACIC TRANSPLANTATION

EVIDENCE AGAINST A PIVOTAL ROLE OF PREFORMED ANTIBODIES IN DELAYED REJECTION OF A GUINEA PIG–TO–RAT HEART XENOGRAFT

Helmut Grimm, MD, PhDa, Petra Mages, MDa, Gertraut Lindemann, MDa, Mechthild Potthoff, MDa, Ulrich Bohnet, MDa, Stephan Korom, MDa, Leander Ermert, MDb

From the Department of General and Thoracic Surgerya and the Institute for Pathology,b University of Giessen, Giessen, Germany.

Address for reprints: Helmut Grimm, MD, PhD, Department of General and Thoracic Surgery, University of Giessen, Rudolf-Buchheim-Strasse 7, D-35392 Giessen, Germany (E-mail: helmut.grimm{at}chiru.med.uni-giessen.de ).

Introduction: Whereas the involvement of elicited xenoantibodies in delayed xenograft rejection is currently being substantiated, this study focuses on the role of the preformed fraction of xenoantibodies.
Methods: To check the influence of the latter, we combined pretransplant complement inactivation (cobra venom factor) and antibody reduction (plasmapheresis) in a guinea pig–to–rat heart transplant model.
Results: Antibody reduction on plasmapheresis before xenografting did not prolong delayed xenorejection in decomplemented rats, although the immunohistologic pattern lacked the immunoglobulin deposits along endothelial walls found in xenografts of merely decomplemented recipients. Astonishingly, plasmapheresis, if carried out 2 days before transplantation, almost tripled xenograft survival, although preformed antibody levels were completely restored and even rebounding at the time of grafting. The pattern and number of infiltrating cells did not differ in dependence of the timing of plasmapheresis nor did the proliferative response of lymphocytes in the mixed lymphocyte reaction differ. However, plasmapheresis led to a retarded decrease of the mononuclear cell tumor necrosis factor {alpha} secretory potential, which correlated well with a diminished immunohistologic staining of tumor necrosis factor {alpha} secreted by graft-infiltrating mononuclear cells.
Conclusion: These findings argue against a pivotal role of preformed xenoantibodies in the pathomechanistic process of delayed xenograft rejection and challenge the therapeutic strategy to reduce preformed xenoantibody levels before xenotransplantation in complement-inactivated recipients.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Hasegawa, K. Okada, Y. Takano, Y. Hiraishi, and Y. Okita
Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response
J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1268 - 1276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The American Association for Thoracic Surgery.